Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Federal Trade Commission
Daiichi Sankyo

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006530

« Back to Dashboard
NDA 006530 describes AVC, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from two suppliers. Additional details are available on the AVC profile page.

The generic ingredient in AVC is sulfanilamide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sulfanilamide profile page.

Summary for NDA: 006530

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 006530

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CREAM;VAGINAL 006530 NDA Meda Pharmaceuticals 0037-6631 0037-6631-04 1 TUBE, WITH APPLICATOR in 1 CARTON (0037-6631-04) > 113 g in 1 TUBE, WITH APPLICATOR
CREAM;VAGINAL 006530 NDA Jazz Pharmaceuticals Commercial Corp. 66663-103 66663-103-00 1 TUBE, WITH APPLICATOR in 1 CARTON (66663-103-00) > 113 g in 1 TUBE, WITH APPLICATOR

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CREAM;VAGINALStrength15%
Approval Date:Jan 27, 1987TE:RLD:Yes

Summary for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;VAGINALStrength1.05GM
Approval Date:Jan 27, 1987TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Johnson and Johnson
Queensland Health
US Department of Justice
Boehringer Ingelheim
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus